Industry Verticals »

All Categories

Insights »

About TMR »

GAS Pharyngitis Diagnostics Market

GAS Pharyngitis Diagnostics Market (Product: Rapid Test Kit, Culture Test, and PCR-based Test; and End User: Hospitals, Physician Clinics, and Diagnostics Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Rising Number of Deaths Due to Rheumatic Heart Diseases to Accelerate Market Growth

As per the report published by the U.S. National Health Statistics Report, GAS pharyngitis is one of the primary causes that has led to an increase in the number of patients being admitted to the emergency ward in the country. Moreover, group A beta-hemolytic streptococcus is one of the leading causes of streptococcal pharyngitis among adults and children. The diagnosis of strep throat is imperative and increasingly gaining momentum, owing to a surge in the number of deaths due to chronic rheumatic heart disease. GAS pharyngitis diagnostics has, thus, received a great amount of attention over the past few years and gained considerable traction across diagnostic laboratories, hospitals, and physician clinics worldwide.

Companies in the GAS pharyngitis diagnostics market are affected by a range of challenges. At present, one of the biggest challenges within the GAS pharyngitis diagnostics market is providing accurate, efficient, and accessible diagnostics. However, with significant groundwork, an influx of new training programs, growing support from government organizations, and promising outcome from R&D activities, GAS pharyngitis diagnostics is likely to gain significant momentum during the forecast period. Due to these factors, the global GAS pharyngitis diagnostics market is expected to attain a market value of ~US$ 204 Mn by the end of 2027.

gas pharyngitis diagnostics market infographic

Rapid Test Kits to Retain Popularity; Culture Tests Gain Ground

GAS pharyngitis diagnostics continues to remain a major challenge due to which, opting for the right treatment remains a constant roadblock. In the current scenario, antibiotics are primarily used to treat pharyngitis from bacterial infection. However, due to the significant rise in antimicrobial resistance, the adoption of antibiotics is declining-a factor that is expected to encourage research activities and finding an accurate diagnosis.

Culture tests are predominantly regarded as the gold standard in the GAS pharyngitis diagnostics market. However, the downside of these culture-based tests includes the large time gap between sample collection and attaining results. Over the past decade, due to a significant amount of research and advancements in the medical field, an array of rapid tests have emerged within the GAS pharyngitis diagnostics market that is predominantly based on immunoassays and in recent times, on molecular assays. While immunoassays, including immunochromatographic assays, optical immunoassays, and enzyme immunoassays are deployed, molecular assays that are based on techniques such as polymerase chain reaction, DNA probes, and fluorescence in situ hybridization are also gaining considerable traction across the world.

Primary factors that are expected to accelerate the demand for rapid tests in the upcoming years include faster diagnostics and prevention of inappropriate use of antibiotics. At present, research and development activities are largely aimed at increasing the accuracy of rapid tests and make them more cost-effective. Despite the growing adoption of rapid tests, culture tests for antimicrobial susceptibility testing will continue to stay in demand. Rapid test kit is set to dominate the GAS pharyngitis diagnostics market in terms of market share and value.

Market Participants Focus on Development of New Assays for Faster Results

For companies operating within the current GAS pharyngitis diagnostics market, improving accuracy and speed of the overall diagnostic procedure is expected to be a major area of interest. Several companies are currently in the process of attaining approval from the U.S. Food and Drug Administration (FDA). Some of the major players involved in the market, including Quidel Corporation and Abbott, are increasingly allocating funds for the development of new assays and a host of healthcare products. For instance, in October 2018, Abbott revealed that the U.S. FDA approved the company’s Influenza A & B 2 and Strep A 2 molecular assays. In addition, with the development of new assays, GAS pharyngitis diagnostics results can be achieved at a faster rate. In addition, the recently developed assays can be deployed in both patient as well as inpatient settings, such as physician offices, emergency rooms, walk-in clinics, etc. With additional research, new and cost-effective GAS pharyngitis diagnostics solutions that are currently in the research phase are projected to enter the market.

gas pharyngitis diagnostics market segmentation

Analysts’ Viewpoint

The global GAS pharyngitis diagnostics market is expected to grow at a CAGR of 2.5% during the forecast period. Some of the key factors that will most likely influence the growth of the market include a consistent growth in the number of GAS pharyngitis patients, high focus on research and development, and promising results offered by rapid test kits and continual support from government bodies worldwide. While culture tests will continue to remain an integral part of the entire GAS pharyngitis diagnostics market, the demand for rapid test kits will remain higher during the forecast period. Companies should continue investing in research and development activities and focus on obtaining approval from the FDA for their new assays.

GAS Pharyngitis Diagnostics Market: Overview

  • Pharyngitis is inflammation of the pharynx, which is in the back of the throat. It is most often referred to simply as sore throat. Numerous viral and bacterial agents can cause pharyngitis and GAS pharyngitis is one of the bacterial infections caused by specially group A streptococcus.
  • The market for GAS pharyngitis diagnostic is likely to expand significantly, as the incidence of GAS pharyngitis rises, especially among adolescents
  • According to Regents of the University of California, every year, more than 600 million cases of pharyngitis are reported worldwide and group A streptococcus (gas) is responsible for more than 30% of pharyngitis infection. Moreover, group A streptococcus (GAS) is the trigger for post-infectious immune-mediated rheumatic heart disease, which kills more than 300,000 people annually. 

GAS Pharyngitis Diagnostics: Market Drivers

  • Several companies, as a part of strategy, are investing a high proportion of their revenue in pipeline product development with an objective to generate tests with high efficacy, within a short period, along with research in first-in-type test candidates, which is driving the market. For instance, in 2019, GenePOC Inc., received the U.S. FDA clearance for GenePOC Strep A assay. The GenePOC Strep A assay can provide results from up to eight samples as early as within 42 minutes for positive specimens and in approximately 70 minutes for negative specimens, without the need for culture confirmation.
  • Moreover, incidence and prevalence of GAS pharyngitis infection are gradually increasing across the globe. For instance, according to the CDC, report 2017, the incident rate of preventable invasive group A streptococcal disease increased from 5.8 per 100,000 in 2016 to 7.26 per 100,000 in 2017. This is also rising the demand for GAS pharyngitis diagnostic. 

GAS Pharyngitis Diagnostics: Market Segmentation

  • Based on product, the global GAS pharyngitis diagnostics market has been divided into rapid test kit, culture test, and PCR-based test
  • Based on end user, the global GAS pharyngitis diagnostics market has been classified into hospitals, physician clinics, and diagnostic laboratories
  • Each segment of the GAS pharyngitis diagnostics market has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights
  • The report (GAS pharyngitis diagnostics) provides current and future revenue (US$ Mn) for each of these segments from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (%CAGR) has been provided for each segment of GAS pharyngitis diagnostics market from 2019 to 2027, along with market size estimations. 

GAS Pharyngitis Diagnostics Market: Regional Overview

  • In terms of region, the global GAS pharyngitis diagnostics market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.
  • North America is expected to dominate the GAS pharyngitis diagnostics market during the forecast period. The GAS pharyngitis diagnostics market in Asia Pacific is estimated to expand at a high CAGR during the forecast period.
  • The current and future values in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
  • The study also offers a list of recommendations, highlights, and useful insights of the GAS pharyngitis diagnostics market which would help new companies willing to enter the GAS pharyngitis diagnostics market and existing companies to increase market shares, and help in the decision-making process 

GAS Pharyngitis Diagnostics Market: Major Players 

  • The report concludes with the company profiles section that includes key information about the major players in the global GAS pharyngitis diagnostics market
  • Key players analyzed in this report are
    • Quidel Corporation
    • BD
    • Abbott Laboratories
    • bioMérieux SA
    • Hoffmann-La Roche Ltd
    • Beckman Coulter, Inc. (Danaher)
    • Meridian Bioscience, Inc.
    • DiaSorin S.p.A.
    • Sekisui Diagnostics
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Frequently Asked Questions

What is the total market worth of GAS pharyngitis diagnostics market?

GAS pharyngitis diagnostics market is expected to attain a market value of ~US$ 204 Mn by the end of 2027

What is the anticipated CAGR of the GAS pharyngitis diagnostics market in the forecast period?

GAS pharyngitis diagnostics market to expand at a CAGR of 2.5% from 2019 to 2027

What are the key driving factors for the growth of the GAS pharyngitis diagnostics market?

GAS pharyngitis diagnostics market is driven by increase in incidence and prevalence of GAS pharyngitis infection across the globe

Which region is expected to project the highest market share in the global GAS pharyngitis diagnostics market?

North America accounted for a major share of the global GAS pharyngitis diagnostics market during the forecast period

Who are the key players in the global GAS pharyngitis diagnostics market?

Key players in the GAS pharyngitis diagnostics market include Quidel Corporation, BD, Abbott Laboratories, bioMérieux SA, Hoffmann-La Roche Ltd, Beckman Coulter, Inc. (Danaher)

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global GAS Pharyngitis Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Strategies of Top 3 Players Operating in the Market

    5.2. Key Industrial Events

6. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Product, 2017-2027 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2027

        6.3.1. Rapid Test Kit

        6.3.2. Culture Test

        6.3.3. PCR-based Test

    6.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Product 

7. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by End-user, 2017-2027 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017–2027

        7.3.1. Physician Office

        7.3.2. Diagnostic Laboratories

        7.3.3. Hospitals

    7.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by End-user

8. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Region, 2017-2027

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Region

9. North America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017–2027

        9.2.1. Rapid Test Kit

        9.2.2. Culture Test

        9.2.3. PCR-based Test

    9.3. North America GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027

        9.3.1. Physician Office

        9.3.2. Diagnostic Laboratories

        9.3.3. Hospitals

    9.4. North America GAS Pharyngitis Diagnostics Market Value Forecast, by Country, 2017-2027 

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America GAS Pharyngitis Diagnostics Market Attractiveness Analysis 

        9.5.1. By Product 

        9.5.2. By End-user

        9.5.3. By Country

10. Europe GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027

    10.1. Introduction

        10.1.1. Key Finding

    10.2. Europe GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027

        10.2.1. Rapid Test Kit

        10.2.2. Culture Test

        10.2.3. PCR-based Test

    10.3. Europe GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027

        10.3.1. Physician Office

        10.3.2. Diagnostic Laboratories

        10.3.3. Hospitals

    10.4. Europe GAS Pharyngitis Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Europe GAS Pharyngitis Diagnostics Market Attractiveness Analysis 

        10.5.1. By Product 

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027

    11.1. Introduction

        11.1.1. Key Finding

    11.2. Asia Pacific GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027

        11.2.1. Rapid Test Kit

        11.2.2. Culture Test

        11.2.3. PCR-based Test

    11.3. Asia Pacific GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027

        11.3.1. Physician Office

        11.3.2. Diagnostic Laboratories

        11.3.3. Hospitals

    11.4. Asia Pacific GAS Pharyngitis Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027

    12.1. Introduction

        12.1.1. Key Finding

    12.2. Latin America GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027

        12.2.1. Rapid Test Kit

        12.2.2. Culture Test

        12.2.3. PCR-based Test

    12.3. Latin America GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027

        12.3.1. Physician Office

        12.3.2. Diagnostic Laboratories

        12.3.3. Hospitals

    12.4. Latin America GAS Pharyngitis Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America GAS Pharyngitis Diagnostics Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027

    13.1. Introduction

        13.1.1. Key Finding

    13.2. Middle East & Africa GAS Pharyngitis Diagnostics Market Value Forecast, by Product, 2017-2027

        13.2.1. Rapid Test Kit

        13.2.2. Culture Test

        13.2.3. PCR-based Test

    13.3. Middle East & Africa GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-2027

        13.3.1. Physician Office

        13.3.2. Diagnostic Laboratories

        13.3.3. Hospitals

    13.4. Middle East & Africa GAS Pharyngitis Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness Analysis 

        13.5.1. By Product 

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Comparative Ranking Analysis by Company (2018)

    14.3. Company Profiles

        14.3.1. Quidel Corporation

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Company Financials

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. BD

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Company Financials

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. Abbott Laboratories

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Company Financials

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. bioMérieux SA 

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Company Financials

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. F. Hoffmann-La Roche Ltd

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Company Financials

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6. Beckman Coulter, Inc. (Danaher)

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Company Financials

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. Meridian Bioscience, Inc. 

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Company Financials

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

        14.3.8. DiaSorin S.p.A.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Company Financials

            14.3.8.3. Growth Strategies

            14.3.8.4. SWOT Analysis

        14.3.9. Sekisui Diagnostics

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Company Financials

            14.3.9.3. Growth Strategies

            14.3.9.4. SWOT Analysis

List of Tables

Table 01: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 03: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 04: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027 

Table 05: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 06: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 08: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 09: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 11: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 12: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 13: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 14: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 15: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 16: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 17: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 18: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global GAS Pharyngitis Diagnostics market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Key Industrial Development in the GAS Pharyngitis Diagnostic Companies (1/2)

Figure 03: Key Industrial Development in the GAS Pharyngitis Diagnostic Companies (2/2)

Figure 04: Global GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 05: Global GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018

Figure 06: Global GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018

Figure 07: Global GAS Pharyngitis Diagnostics Market Value Share, by Region, 2018

Figure 08: Global GAS Pharyngitis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027

Figure 09: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rapid Test Kit, 2017–2027

Figure 10: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Test, 2017–2027

Figure 11: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR-based Test, 2017-2027

Figure 12: Global GAS Pharyngitis Diagnostics Market Attractiveness Analysis, by Product, 2019–2027

Figure 13: Global GAS Pharyngitis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 14: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician Clinics, 2017–2027

Figure 15: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

Figure 16: Global GAS Pharyngitis Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2027

Figure 17: Global GAS Pharyngitis Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027

Figure 18: Global GAS Pharyngitis Diagnostics Market Value Share, by Region, 2018 and 2027

Figure 19: Global GAS Pharyngitis Diagnostics Market Attractiveness Analysis, by Region, 2019–2027

Figure 20: North America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 21: North America GAS Pharyngitis Diagnostics Market Value Share, by Country, 2018 and 2027

Figure 22: North America GAS Pharyngitis Diagnostics Market Attractiveness, by Country, 2019–2027

Figure 23: North America GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027

Figure 24: North America GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 25: North America GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027

Figure 26: North America GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027

Figure 27: Europe GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 28: Europe GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 29: Europe GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 30: Europe GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027

Figure 31: Europe GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 32: Europe GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027

Figure 33: Europe GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027

Figure 34: Asia Pacific GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 35: Asia Pacific GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 36: Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 37: Asia Pacific GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027

Figure 38: Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 39: Asia Pacific GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027

Figure 40: Asia Pacific GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027

Figure 41: Latin America GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 42: Latin America GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 43: Latin America GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 44: Latin America GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027

Figure 45: Latin America GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 46: Latin America GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027

Figure 47: Latin America GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027

Figure 48: Middle East & Africa GAS Pharyngitis Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 49: Middle East & Africa GAS Pharyngitis Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 50: Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 51: Middle East & Africa GAS Pharyngitis Diagnostics Market Value Share, by Product, 2018 and 2027

Figure 52: Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 53: Middle East & Africa GAS Pharyngitis Diagnostics Market Value Share, by End-user, 2018 and 2027

Figure 54: Middle East & Africa GAS Pharyngitis Diagnostics Market Attractiveness, by End-user, 2019–2027

Figure 55: Quidel Corporation Breakdown of Net Sales, by Region, 2018 (%)

Figure 56: Quidel Corporation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 57: Becton, Dickinson. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 58: Becton, Dickinson. Breakdown of Net Sales (%), by Region/Country, 2018

Figure 59: Becton, Dickinson. Revenue Breakdown of Net Sales (%), by Business Segment, 2018

Figure 60: Becton, Dickinson. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 61: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 62: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 63: Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 64: Breakdown of Net Sales (% Share), by Region, 2018

Figure 65: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 66: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 67: Breakdown of Net Sales (% Share), by Application, 2018

Figure 68: Breakdown of Net Sales (% Share), by Region, 2018

Figure 69: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 71: Breakdown of Net Sales (% Share), by Business Segment, 2018

Figure 72: Breakdown of Net Sales (% Share), by Region, 2018

Figure 73: Danaher Diagnostics Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 74: R&D Intensity (US$ Mn), Diagnostics Business Segment, 2015–2017

Figure 75: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Region, 2018

Figure 76: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Product, 2018

Figure 77: Meridian Bioscience Inc. Breakdown of Net Sales, by Region, 2018 (%)

Figure 78: Meridian Bioscience Inc. Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 79: DiaSorin S.p.A. Revenue (US$ Mn), 2015–2018

Figure 80: DiaSorin S.p.A. R&D Expenses (US$ Mn), 2015–2018

Figure 81: DiaSorin S.p.A. Breakdown of Net Sales (%), by Region, 2018

Figure 82: DiaSorin S.p.A. Sales and Marketing Expenses (US$ Mn, 2015–2018

Copyright © Transparency Market Research, Inc. All Rights reserved

GAS Pharyngitis Diagnostics Market

Schedule a Call